1 year return (CAGR)
123.59%
Amylyx Pharmaceuticals Inc Exchange (NASDAQ, USD)
AMLX
30.14
-0.47 (-1.52%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
16.87%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.36B
Price/Sales
-
Ent value
3.33B
Price/Book
14.04
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
14.86%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 30.73 |
| Daily high | 31.00 |
| Daily low | 29.83 |
| Daily Volume | 1.42M |
| All-time high | 40.93 |
| 1y analyst estimate | 42.36 |
| Beta | -0.12 |
| EPS (TTM) | -1.37 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AMLX | S&P500 | |
| Current price drop from All-time high | -26.36% | -1.38% |
| Highest price drop | -96.04% | -56.47% |
| Date of highest drop | 18 Jun 2024 | 9 Mar 2009 |
| Avg drop from high | -58.10% | -10.68% |
| Avg time to new high | 46 days | 12 days |
| Max time to new high | 918 days | 1805 days |
News
